-
1
-
-
0032511583
-
Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
2
-
-
33645861392
-
Summary of revisions for the 2006 Clinical Practice Recommendations
-
Members of the Professional Practice Committee
-
Members of the Professional Practice Committee. Summary of revisions for the 2006 Clinical Practice Recommendations. Diabetes Care 29 Suppl 1 (2006) S3
-
(2006)
Diabetes Care
, vol.29
, Issue.SUPPL. 1
-
-
-
3
-
-
0031972156
-
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
-
for the UK Prospective Diabetes Study (UKPDS) Group
-
Matthews D., Cull C., Stratton I., et al., for the UK Prospective Diabetes Study (UKPDS) Group. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. Diabet Med 15 (1998) 297-303
-
(1998)
Diabet Med
, vol.15
, pp. 297-303
-
-
Matthews, D.1
Cull, C.2
Stratton, I.3
-
4
-
-
0037167920
-
Clinical practice
-
Initial management of glycemia in type 2 diabetes mellitus
-
Nathan D. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 347 (2002) 1342-1349
-
(2002)
N Engl J Med
, vol.347
, pp. 1342-1349
-
-
Nathan, D.1
-
5
-
-
0023777821
-
Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes
-
Glaser B., Leibovich G., Nesher R., et al. Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes. Acta Endocrinol (Copenh) 118 (1988) 365-373
-
(1988)
Acta Endocrinol (Copenh)
, vol.118
, pp. 365-373
-
-
Glaser, B.1
Leibovich, G.2
Nesher, R.3
-
6
-
-
0036274789
-
A rapid increase in beta-cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatment
-
Karvestedt L., Andersson G., Efendic S., and Grill V. A rapid increase in beta-cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatment. J Intern Med 251 (2002) 307-316
-
(2002)
J Intern Med
, vol.251
, pp. 307-316
-
-
Karvestedt, L.1
Andersson, G.2
Efendic, S.3
Grill, V.4
-
7
-
-
0030751382
-
Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment
-
Ilkova H., Glaser B., Tunckale A., et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 20 (1997) 1353-1356
-
(1997)
Diabetes Care
, vol.20
, pp. 1353-1356
-
-
Ilkova, H.1
Glaser, B.2
Tunckale, A.3
-
8
-
-
2342587418
-
Short-term intensive insulin therapy in newly diagnosed type 2 diabetes
-
Ryan E., Imes S., and Wallace C. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care 27 (2004) 1028-1032
-
(2004)
Diabetes Care
, vol.27
, pp. 1028-1032
-
-
Ryan, E.1
Imes, S.2
Wallace, C.3
-
9
-
-
7444234167
-
Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function
-
Li Y., Xu W., Liao Z., et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 27 (2004) 2597-2602
-
(2004)
Diabetes Care
, vol.27
, pp. 2597-2602
-
-
Li, Y.1
Xu, W.2
Liao, Z.3
-
10
-
-
0029149751
-
Effects of early introduction of intensive insulin therapy on the clinical course in nonobese NIDDM patients
-
Kayashima T., Yamaguchi K., Konno Y., et al. Effects of early introduction of intensive insulin therapy on the clinical course in nonobese NIDDM patients. Diabet Res Clin Pract 28 (1995) 119-125
-
(1995)
Diabet Res Clin Pract
, vol.28
, pp. 119-125
-
-
Kayashima, T.1
Yamaguchi, K.2
Konno, Y.3
-
11
-
-
0041523870
-
Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients
-
Alvarsson M., Sundkvist G., Lager I., et al. Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. Diabetes Care 26 (2003) 2231-2237
-
(2003)
Diabetes Care
, vol.26
, pp. 2231-2237
-
-
Alvarsson, M.1
Sundkvist, G.2
Lager, I.3
-
12
-
-
0027389342
-
Intensive conventional insulin therapy for type II diabetes
-
Metabolic effects during a 6-mo outpatient trial
-
Henry R., Gumbiner B., Ditzler T., et al. Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial. Diabetes Care 16 (1993) 21-31
-
(1993)
Diabetes Care
, vol.16
, pp. 21-31
-
-
Henry, R.1
Gumbiner, B.2
Ditzler, T.3
-
13
-
-
0344609217
-
Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus
-
Makimattila S., Nikkila K., and Yki-Jarvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus. Diabetologia 42 (1999) 406-412
-
(1999)
Diabetologia
, vol.42
, pp. 406-412
-
-
Makimattila, S.1
Nikkila, K.2
Yki-Jarvinen, H.3
-
14
-
-
0028289461
-
Long-term improvement of glycemic control by insulin treatment in NIDDM patients with secondary failure
-
Lindstrom T., Eriksson P., Olsson A., and Arnqvist H. Long-term improvement of glycemic control by insulin treatment in NIDDM patients with secondary failure. Diabetes Care 17 (1994) 719-721
-
(1994)
Diabetes Care
, vol.17
, pp. 719-721
-
-
Lindstrom, T.1
Eriksson, P.2
Olsson, A.3
Arnqvist, H.4
-
15
-
-
9844269567
-
Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus
-
Yki-Jarvinen H., Ryysy L., Kauppila M., et al. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82 (1997) 4037-4043
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 4037-4043
-
-
Yki-Jarvinen, H.1
Ryysy, L.2
Kauppila, M.3
-
17
-
-
0034819464
-
Combination therapies with insulin in type 2 diabetes
-
Yki-Jarvinen H. Combination therapies with insulin in type 2 diabetes. Diabetes Care 24 (2001) 758-767
-
(2001)
Diabetes Care
, vol.24
, pp. 758-767
-
-
Yki-Jarvinen, H.1
-
18
-
-
0035486744
-
Insulin therapy does not itself induce weight gain in patients with type 2 diabetes
-
Larger E., Rufat P., DuBois-Laforgue D., and Ledoux S. Insulin therapy does not itself induce weight gain in patients with type 2 diabetes. Diabetes Care 24 (2001) 1849-1850
-
(2001)
Diabetes Care
, vol.24
, pp. 1849-1850
-
-
Larger, E.1
Rufat, P.2
DuBois-Laforgue, D.3
Ledoux, S.4
-
19
-
-
0033928159
-
Effects of insulin on muscle tissue
-
Wolfe R. Effects of insulin on muscle tissue. Curr Opin Clin Nutr Metab Care 3 (2000) 67-71
-
(2000)
Curr Opin Clin Nutr Metab Care
, vol.3
, pp. 67-71
-
-
Wolfe, R.1
-
20
-
-
0035038782
-
Mechanisms of nutritional and hormonal regulation of lipogenesis
-
Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep 2 (2001) 282-286
-
(2001)
EMBO Rep
, vol.2
, pp. 282-286
-
-
Kersten, S.1
-
22
-
-
4143116687
-
Weight gain during insulin therapy in patients with type 2 diabetes mellitus
-
Heller S. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Diabetes Res Clin Proct. 65 Suppl 1 (2004) S23-S27
-
(2004)
Diabetes Res Clin Proct.
, vol.65
, Issue.SUPPL. 1
-
-
Heller, S.1
-
23
-
-
0035516193
-
Changes in BMI and weight before and after the development of type 2 diabetes
-
Looker H., Knowler W., and Hanson R. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care 24 (2001) 1917-1922
-
(2001)
Diabetes Care
, vol.24
, pp. 1917-1922
-
-
Looker, H.1
Knowler, W.2
Hanson, R.3
-
24
-
-
0018341014
-
Diabetes and cardiovascular risk factors: The Framingham study
-
Kannel W., and McGee D. Diabetes and cardiovascular risk factors: The Framingham study. Circulation 59 (1979) 8-13
-
(1979)
Circulation
, vol.59
, pp. 8-13
-
-
Kannel, W.1
McGee, D.2
-
25
-
-
0027437262
-
Medical hazards of obesity
-
Pi-Sunyer F. Medical hazards of obesity. Ann Intern Med. 119 (1993) 655-660
-
(1993)
Ann Intern Med.
, vol.119
, pp. 655-660
-
-
Pi-Sunyer, F.1
-
26
-
-
0025630035
-
Insulin use in NIDDM
-
Genuth S. Insulin use in NIDDM. Diabetes Care 13 (1990) 1240-1264
-
(1990)
Diabetes Care
, vol.13
, pp. 1240-1264
-
-
Genuth, S.1
-
27
-
-
0019981441
-
Insulin treatment reverses the insulin resistance of type II diabetes mellitus
-
Scarlett J., Gray R., Griffin J., et al. Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care 5 (1982) 353-363
-
(1982)
Diabetes Care
, vol.5
, pp. 353-363
-
-
Scarlett, J.1
Gray, R.2
Griffin, J.3
-
28
-
-
0021223411
-
Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal
-
Andrews W., Vasquez B., Nagulesparan M., et al. Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes 33 (1984) 634-642
-
(1984)
Diabetes
, vol.33
, pp. 634-642
-
-
Andrews, W.1
Vasquez, B.2
Nagulesparan, M.3
-
29
-
-
0021990787
-
The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus
-
Garvey W., Olefsky J., Griffin J., et al. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34 (1985) 222-234
-
(1985)
Diabetes
, vol.34
, pp. 222-234
-
-
Garvey, W.1
Olefsky, J.2
Griffin, J.3
-
30
-
-
0036932148
-
A truly deadly quartet: Obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia
-
Nambi V., Hoogwerf R., and Sprecher D. A truly deadly quartet: Obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia. Cleve Clinic J Med 69 (2002) 985-989
-
(2002)
Cleve Clinic J Med
, vol.69
, pp. 985-989
-
-
Nambi, V.1
Hoogwerf, R.2
Sprecher, D.3
-
31
-
-
0024342099
-
Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus
-
Groop L., Widen E., Franssila-Kallunki A., et al. Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 32 (1989) 599-605
-
(1989)
Diabetologia
, vol.32
, pp. 599-605
-
-
Groop, L.1
Widen, E.2
Franssila-Kallunki, A.3
-
32
-
-
0035668504
-
The effects of intensive glycaemic control on body composition in patients with type 2 diabetes
-
Bagg W., Plank L., Gamble G., et al. The effects of intensive glycaemic control on body composition in patients with type 2 diabetes. Diabetes Obes Metab 3 (2001) 410-416
-
(2001)
Diabetes Obes Metab
, vol.3
, pp. 410-416
-
-
Bagg, W.1
Plank, L.2
Gamble, G.3
-
33
-
-
0029147687
-
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
-
Ohkubo Y., Kishikawa H., Araki E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 28 (1995) 103-117
-
(1995)
Diabetes Res Clin Pract
, vol.28
, pp. 103-117
-
-
Ohkubo, Y.1
Kishikawa, H.2
Araki, E.3
-
34
-
-
0034641568
-
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
-
Stratton I., Adler A., Neil H., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321 (2000) 405-412
-
(2000)
BMJ
, vol.321
, pp. 405-412
-
-
Stratton, I.1
Adler, A.2
Neil, H.3
-
35
-
-
0030974812
-
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
-
for the DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group
-
Malmberg K., for the DIGAMI (Diabetes Mellitus, and Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 314 (1997) 1512-1515
-
(1997)
BMJ
, vol.314
, pp. 1512-1515
-
-
Malmberg, K.1
-
36
-
-
29144453326
-
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
-
for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group
-
Nathan D., Cleary P., Backlund J., et al., for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005) 2643-2653
-
(2005)
N Engl J Med
, vol.353
, pp. 2643-2653
-
-
Nathan, D.1
Cleary, P.2
Backlund, J.3
-
37
-
-
0030947226
-
Mealtime treatment with insulin ana log improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus
-
for the Multicenter Insulin Lispro Study Group
-
Anderson Jr. J., Brunelle R., Keohane P., et al., for the Multicenter Insulin Lispro Study Group. Mealtime treatment with insulin ana log improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Arch Intern Med 157 (1997) 1249-1255
-
(1997)
Arch Intern Med
, vol.157
, pp. 1249-1255
-
-
Anderson Jr., J.1
Brunelle, R.2
Keohane, P.3
-
38
-
-
0033867021
-
Less nocturnal hypoglycemia and better postdinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes
-
for the HOE 901/3002 Study Group
-
Yki-Jarvinen H., Dressler A., Ziemen M., and for the HOE 901/3002 Study Group. Less nocturnal hypoglycemia and better postdinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care 23 (2000) 1130-1136
-
(2000)
Diabetes Care
, vol.23
, pp. 1130-1136
-
-
Yki-Jarvinen, H.1
Dressler, A.2
Ziemen, M.3
-
39
-
-
0034827469
-
Basal insulin therapy in type 2 diabetes: 28-Week comparison of insulin glargine (HOE 901) and NPH insulin
-
Rosenstock J., Schwartz S., Clark Jr. C., et al. Basal insulin therapy in type 2 diabetes: 28-Week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care 24 (2001) 631-636
-
(2001)
Diabetes Care
, vol.24
, pp. 631-636
-
-
Rosenstock, J.1
Schwartz, S.2
Clark Jr., C.3
-
40
-
-
12744274870
-
Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes
-
Hack T., Tiengo A., Draeger E., et al. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes. Diabetes Obes Metab 7 (2005) 56-64
-
(2005)
Diabetes Obes Metab
, vol.7
, pp. 56-64
-
-
Hack, T.1
Tiengo, A.2
Draeger, E.3
-
41
-
-
0343724362
-
Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus
-
A randomized, controlled trial
-
Yki-Jarvinen H., Ryysy L., Nikkila K., et al. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 130 (1999) 389-396
-
(1999)
Ann Intern Med
, vol.130
, pp. 389-396
-
-
Yki-Jarvinen, H.1
Ryysy, L.2
Nikkila, K.3
-
42
-
-
33646801658
-
Exenatide and pramlintide: New glucose-lowering agents for treating diabetes mellitus
-
Hoogwerf R. Exenatide and pramlintide: New glucose-lowering agents for treating diabetes mellitus. Cleve Clin J Med. 73 (2006) 477-484
-
(2006)
Cleve Clin J Med.
, vol.73
, pp. 477-484
-
-
Hoogwerf, R.1
-
43
-
-
0035512619
-
Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control
-
Gokcel A., Karakose H., Ertorer E., et al. Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control. Diabetes Care 24 (2001) 1957-1960
-
(2001)
Diabetes Care
, vol.24
, pp. 1957-1960
-
-
Gokcel, A.1
Karakose, H.2
Ertorer, E.3
-
44
-
-
0036598137
-
Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial
-
Kelley D., Bray G., Pi-Sunyer F., et al. Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial. Diabetes Care 25 (2002) 1033-1041
-
(2002)
Diabetes Care
, vol.25
, pp. 1033-1041
-
-
Kelley, D.1
Bray, G.2
Pi-Sunyer, F.3
-
45
-
-
8644223451
-
Comparison of metabolic effects of orlistat and sibutramine treatment in type 2 diabetic obese patients
-
Derosa G., Cicero A., Murdolo G., et al. Comparison of metabolic effects of orlistat and sibutramine treatment in type 2 diabetic obese patients. Diabetes Nutr Metob 17 (2004) 222-229
-
(2004)
Diabetes Nutr Metob
, vol.17
, pp. 222-229
-
-
Derosa, G.1
Cicero, A.2
Murdolo, G.3
|